Skip to Content

News: March, 2021

Why are young people getting colorectal cancer?

Wednesday, March 3rd, 2021

Research will accompany the Vanderbilt-Ingram Cancer Center Young Adult Program, delving into three very important questions about colorectal cancer: why these cancers are happening at such a young age; why survival is shorter in young adult patients; and whether these young patients should be receiving the same treatments as older patients with colorectal cancer. “All […]

Fresh Start

Wednesday, March 3rd, 2021

When Sonia Richard was diagnosed with stage 3c colorectal cancer at age 30, she felt lost. “I didn’t know anyone my age who had dealt with cancer,” Richard said. The Vanderbilt-Ingram Cancer Center Young Adult Program is a new initiative to help people diagnosed in the prime of their lives. It’s designed for patients ages […]

Q+A: Clinical Trials

Tuesday, March 2nd, 2021

Brian Rini, MD, Ingram Professor of Cancer Research and chief of Clinical Trials at Vanderbilt-Ingram Cancer Center, is an internationally recognized leader in clinical drug development. Q Why should a cancer patient participate in a clinical trial? A Every drug that is FDA approved today has come through the clinical trials system, so we don’t […]

Journal Watch

Monday, March 1st, 2021

New strategy for reducing tumor growth Ann Richmond, PhD, and colleagues have discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma. The findings, reported Dec. 18, 2020, in the journal Cancer Immunology Research, add mechanistic insight and support for the therapeutic […]

Personalized Care

Monday, March 1st, 2021

A cancer diagnosis is startling for anyone at any age, but it’s particularly daunting for young adults. Whether they’ve already charted a life course or are still considering various paths, a cancer diagnosis can cast them adrift and leave them spinning, not knowing which direction to turn. The Vanderbilt-Ingram Cancer Center Young Adult Program helps […]

Patient Advocates

Monday, March 1st, 2021

People experienced with a cancer journey often become patient advocates. Their advocacy includes serving in organizations that promote research and education, increasing awareness through social media and providing guidance and support for newly diagnosed patients.   Diagnosed with prostate cancer in 2014 and successfully treated at Vanderbilt in 2015, Ira Baxter now volunteers as executive […]

A Big Family

Monday, March 1st, 2021

The darkest hour came for me on Nov. 19, 2018. As I was chit-chatting with the radiology technician and giving advice for her daughter on navigating pre-medical requirements in college, she was taking X-rays of the cancer that I didn’t know was growing inside of me. “Tell her to major in something completely different from […]

Molecular Automation

Monday, March 1st, 2021

As medical science advances upon the molecular drivers of different cancers, and as cancer treatment consequently becomes more targeted and precise, clinical testing for molecular alterations has come online over the past decade to help clinicians match patients to these newer treatments. “We have pills that allow us to target certain genomic alterations in tumors, […]

Expanded Footprint

Monday, March 1st, 2021

Vanderbilt-Ingram Cancer Center has established new leadership positions as the network expands the reach of its clinical services. The new positions are executive medical director, senior medical director for VICC Cancer Care Network and Strategy and chief surgical officer.   Laura Goff, MD, MSCI, associate professor of Medicine, has been named the executive medical director […]

All-Encompassing Care

Monday, March 1st, 2021

Cancers that occur early in people’s lives put a damper on their dreams and waylay their plans. The Adolescent and Young Adult Cancer Program guides them through this difficult time. The program offers subspeciality care for cancers that commonly occur in people between the ages of 15 and 29, including testicular cancer, ovarian cancer, bone […]

Next Page »